SCHEMBL19944104

SCHEMBL19944104

NC1CC(N)C2OC3(CCCCC3)OC2C1OC1OC2COC3(CCCCC3)OC2C(OS(=O)(=O)C(F)(F)F)C1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19944063 0.84 — —
SCHEMBL19619212 0.82 LRAT (0.30) —
SCHEMBL19944109 0.81 — —
SCHEMBL19619250 0.80 LRAT (0.36) —
SCHEMBL13873391 0.74 — —
SCHEMBL13890114 0.74 — —
SCHEMBL19619252 0.73 — —
SCHEMBL19944540 0.71 POLB (0.46) —
SCHEMBL19619219 0.71 — —
SCHEMBL15828080 0.62 DRD2 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180064743-A1 NOVEL AMINOGLYCOSIDES AND USES THEREOF IN THE TREATMENT OF GENETIC DISORDERS TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2018-03-08 — — US disclosed
Send feedback